MENU
+Compare
GPCR
Stock ticker: NASDAQ
AS OF
Oct 21, 04:59 PM (EDT)
Price
$26.90
Change
-$0.97 (-3.48%)
Capitalization
1.61B

GPCR Structure Therapeutics Forecast, Technical & Fundamental Analysis

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs... Show more

GPCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for GPCR with price predictions
Oct 20, 2025

GPCR sees MACD Histogram crosses below signal line

GPCR saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 16, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 29 instances where the indicator turned negative. In of the 29 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for GPCR moved out of overbought territory on October 15, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 9 similar instances where the indicator moved out of overbought territory. In of the 9 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on October 20, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on GPCR as a result. In of 47 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GPCR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

GPCR broke above its upper Bollinger Band on October 09, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The 50-day moving average for GPCR moved above the 200-day moving average on October 16, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GPCR advanced for three days, in of 147 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 50 cases where GPCR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.079) is normal, around the industry mean (23.782). P/E Ratio (0.000) is within average values for comparable stocks, (54.762). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.161). Dividend Yield (0.000) settles around the average of (0.037) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (356.041).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GPCR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GPCR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
GPCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

GPCR is expected to report earnings to fall 25.00% to -27 cents per share on November 12

Structure Therapeutics GPCR Stock Earnings Reports
Q3'25
Est.
$-0.27
Q2'25
Missed
by $0.10
Q1'25
Missed
by $0.02
Q4'24
Beat
by $0.07
Q3'24
Beat
by $0.07
The last earnings report on August 06 showed earnings per share of -36 cents, missing the estimate of -25 cents. With 208.26K shares outstanding, the current market capitalization sits at 1.61B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
601 Gateway Boulevard
Phone
+1 650 457-1978
Employees
93
Web
https://www.structuretx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MBCGX22.04N/A
N/A
MassMutual Blue Chip Growth A
TRGMX21.96N/A
N/A
Nuveen Quant Mid Cap Growth Retire
PBCKX50.01N/A
N/A
Principal Blue Chip Institutional
TNBRX20.61N/A
N/A
1290 SmartBeta Equity R
LZFIX8.74N/A
N/A
Lazard Equity Franchise Inst Shr

GPCR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GPCR has been loosely correlated with CLDX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if GPCR jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GPCR
1D Price
Change %
GPCR100%
+1.79%
CLDX - GPCR
43%
Loosely correlated
+3.13%
IMTX - GPCR
43%
Loosely correlated
+11.04%
TERN - GPCR
42%
Loosely correlated
+2.50%
ARWR - GPCR
42%
Loosely correlated
+4.51%
SYRE - GPCR
41%
Loosely correlated
+4.54%
More